Oxford Science Enterprises
Oxford, United KingdomFounded 2015
Oxford Science Enterprises focuses on early-stage investments in transformational businesses spun out of the University of Oxford, primarily across Life Sciences, Health Tech, AI & Software, and Deep Technology sectors. Their strategy involves providing patient, long-term capital, hands-on venture building, and operational support to guide these companies from inception to global scale.
Deal activity increased 50% year-over-year (9 deals in the last 12 months). Average disclosed round size is $44.8M (across 31 rounds with reported amounts).
Portfolio
33
Fund Size
$1.4B
Top Stage
Series A
Last 12 Mo
9
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
33 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| FFractile | Series D | $200M | Mar 2026 |
| AAllos | Seed | $5M | Jan 2026 |
 Allos AI | Seed | $5M | Jan 2026 |
 Beacon Therapeutics | Series C | — | Jan 2026 |
| SScripta Therapeutics | Seed | $12M | Nov 2025 |
 Valink Therapeutics | Series A | $11.8M | Oct 2025 |
| WWild Bioscience | Series A | $51M | Oct 2025 |
 Kneu Health | Seed | $5.6M | Oct 2025 |
 Ultromics | Series C | $55M | Jul 2025 |
| MMixergy | Unknown | $15.2M | Mar 2025 |
 Salience Labs | Series A | $30M | Feb 2025 |
| Kneu Health | Seed | $1.9M | Jan 2025 |
| FFractile | Seed | $15M | Jul 2024 |
 PQShield | Series B | $37M | Jun 2024 |
 Amber Therapeutics | Series A | $100M | Jun 2024 |
 OQC | Series B | $100M | Mar 2024 |
| OQC | Series C | $100M | Nov 2023 |
 Prolific | Series A | $31.8M | Jul 2023 |
| Beacon Therapeutics | Unknown | $120M | Jun 2023 |
| CCaristo Diagnostics Limited | Series A | $16.3M | Apr 2023 |
 Quantum Motion | Growth | $51M | Feb 2023 |
| Quantum Motion | Series C | $50.5M | Feb 2023 |
 Archangel Lightworks | Seed | $5M | Feb 2023 |
| OOxford Ionics | Series A | $36.6M | Jan 2023 |
| BBehaVR | Series B | $13M | Dec 2022 |
Page 1 of 2
Top Co-Investors
Lansdowne Partners6 shared
Braavos4 shared
British Patient Capital4 shared
INKEF Capital3 shared
Addition2 shared
Berkeley SkyDeck2 shared
Chevron Technology Ventures2 shared
SBI Investment2 shared
Oxford Investment Consultants2 shared
Octopus Ventures2 shared
Bosch Ventures2 shared
Parkwalk Advisors2 shared
IP Group2 shared
AlbionVC1 shared
Apollo Health Ventures1 shared
YZR Capital1 shared
Forbion1 shared
EI Ventures1 shared
Vesalius Biocapital1 shared
Last updated: 12 April 2026